PD1/PD-L1 targeting in advanced soft-tissue sarcomas: a pooled analysis of phase II trials

Journal of Hematology & Oncology ◽

10.1186/s13045-020-00891-5 ◽

2020 ◽

Vol 13 (1) ◽

Author(s):

Antoine Italiano ◽

Carine Bellera ◽

Sandra D’Angelo

Keyword(s):

Soft Tissue ◽

Phase Ii ◽

Soft Tissue Sarcomas ◽

Pooled Analysis ◽

Phase Ii Trials

Download Full-text

Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas

European Journal of Cancer ◽

10.1016/s0959-8049(01)00398-7 ◽

2002 ◽

Vol 38 (4) ◽

pp. 543-549 ◽

Author(s):

M Van Glabbeke ◽

J Verweij ◽

I Judson ◽

O.S Nielsen

Keyword(s):

Soft Tissue ◽

Phase Ii ◽

Soft Tissue Sarcomas ◽

Phase Ii Trials ◽

End Point ◽

Download Full-text

Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials

British Journal of Cancer ◽

10.1038/bjc.2013.524 ◽

2013 ◽

Vol 109 (7) ◽

pp. 1717-1724 ◽

Author(s):

A L Cesne ◽

I Judson ◽

R Maki ◽

F Grosso ◽

S Schuetze ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Pooled Analysis ◽

Phase Ii Trials ◽

Patient Age ◽

Download Full-text

A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas. A southwest oncology group study

Cancer ◽

10.1002/1097-0142(19951201)76:11<2248::aid-cncr2820761111>3.0.co;2-y ◽

1995 ◽

Vol 76 (11) ◽

pp. 2248-2252 ◽

Author(s):

Stanley P. Balcerzak ◽

Jacqueline Benedetti ◽

Geoffrey R. Weiss ◽

Ronald B. Natale

Keyword(s):

Soft Tissue ◽

Phase Ii ◽

Phase Ii Trial ◽

Soft Tissue Sarcomas ◽

Oncology Group ◽

Oncology Group Study ◽

Southwest Oncology Group ◽

Southwest Oncology Group Study

Download Full-text

Phase II study with Docetaxel (Taxotere®) in advanced soft tissue sarcomas of the adult

Annals of Oncology ◽

10.1093/oxfordjournals.annonc.a058909 ◽

1994 ◽

Vol 5 (6) ◽

pp. 539-542 ◽

Author(s):

Q.G.C. M. van Hoesel ◽

J. Verweij ◽

G. Catimel ◽

M. Clavel ◽

P. Kerbrat ◽

...

Keyword(s):

Soft Tissue ◽

Phase Ii ◽

Phase Ii Study ◽

Soft Tissue Sarcomas

Download Full-text

5-years RFS and prognostic factors study in HR-positive HER2-negative breast cancer patients treated with neoadjuvant endocrine therapy : Pooled analysis of two phase II trials

Revue d Épidémiologie et de Santé Publique ◽

10.1016/j.respe.2018.03.097 ◽

2018 ◽

Vol 66 ◽

pp. S154-S155

Author(s):

M. Pulido ◽

F. Lerebours ◽

N. Quenel-Tueux ◽

E. Fourme ◽

M. Debled ◽

...

Keyword(s):

Breast Cancer ◽

Prognostic Factors ◽

Cancer Patients ◽

Endocrine Therapy ◽

Phase Ii ◽

Pooled Analysis ◽

Breast Cancer Patients ◽

Phase Ii Trials ◽

Neoadjuvant Endocrine Therapy ◽

Download Full-text

Phase II trial of methylglyoxal-bis-guanylhydrazone (methyl-GAG) in patients with soft-tissue sarcomas

American Journal of Clinical Oncology ◽

10.1097/00000421-198508000-00008 ◽

1985 ◽

Vol 8 (4) ◽

pp. 316-318 ◽

Author(s):

Peter P. Sordillo ◽

Gordon B. Magill ◽

Sydney Welt

Keyword(s):

Soft Tissue ◽

Phase Ii ◽

Phase Ii Trial ◽

Soft Tissue Sarcomas

Download Full-text

Phase II study of liposomal muramyl tripeptide phosphatidylethanolamine () in advanced soft tissue sarcomas of the adult. An EORTC Soft Tissue and Bone Sarcoma Group study

European Journal of Cancer ◽

10.1016/0959-8049(94)90303-4 ◽

1994 ◽

Vol 30 (6) ◽

pp. 842-843 ◽

Author(s):

J. Verweij ◽

I. Judson ◽

W. Steward ◽

R. Coleman ◽

P. Woll ◽

...

Keyword(s):

Soft Tissue ◽

Phase Ii ◽

Phase Ii Study ◽

Soft Tissue Sarcomas ◽

Download Full-text

Phase II new drug trials in soft tissue sarcomas

Cancer Treatment and Research - Clinical Management of Soft Tissue Sarcomas ◽

10.1007/978-1-4613-2319-8_9 ◽

1986 ◽

pp. 131-138 ◽

Author(s):

Allan T. Van Oosterom

Keyword(s):

Soft Tissue ◽

Phase Ii ◽

Soft Tissue Sarcomas ◽

Drug Trials ◽

Download Full-text

Randomized, Open, Prospective, Phase II Clinical Trial of Doxorubicin (DOXO) vs. Trabectedin Plus Doxo in the First-Line Treatment of Patients (PTS) with Advanced Non-Operable and/or Metastatic Soft Tissue Sarcomas (STS): Geis-20 Study

Annals of Oncology ◽

10.1016/s0923-7534(20)34065-5 ◽

2012 ◽

Vol 23 ◽

pp. ix490 ◽

Author(s):

J. Martin Broto ◽

X. Garcia Del Muro ◽

A. Lopez-Pousa ◽

R. Las De Penas ◽

J. Maurel ◽

...

Keyword(s):

Clinical Trial ◽

Soft Tissue ◽

Phase Ii ◽

Soft Tissue Sarcomas ◽

Phase Ii Clinical Trial ◽

Line Treatment ◽

Prospective Phase ◽

First Line Treatment

Download Full-text

1628MO A new benchmark for designing phase II trials for advanced or metastatic leiomyosarcoma (LMS) patients using progression free survival (PFS) as primary endpoint – an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) meta-analysis

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1854 ◽

2020 ◽

Vol 31 ◽

pp. S977-S978

Author(s):

G. Kantidakis ◽

S. Litiere ◽

A. Neven ◽

M. Vinches ◽

I. Judson ◽

...

Keyword(s):

Soft Tissue ◽

Phase Ii ◽

Primary Endpoint ◽

Meta Analysis ◽

Progression Free Survival ◽

Bone Sarcoma ◽

Phase Ii Trials ◽

Download Full-text